Korlym 300 MG tablet 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FS25J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,999
Award facts
- Contract value 100% obligated
- $13,999.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,999.33 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 23, 2026, for the supply of Korlym 300 mg tablets (28-count packaging). The contract is non-competitive with no set-aside designation and is scheduled for completion by February 13, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order is issued under Amerisourcebergen's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
Korlym (mifepristone) is a glucocorticoid receptor antagonist used in the treatment of hypercortisolism. This procurement supports the Defense Logistics Agency's mission to supply essential pharmaceuticals to military treatment facilities and other federal healthcare systems. The delivery order represents routine pharmaceutical procurement through the established prime vendor relationship, consistent with Amerisourcebergen's extensive role as a critical supplier of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to the Department of Defense and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FS25J?
SPE2DR26FS25J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FS25J worth?
The government has obligated $13,999 on SPE2DR26FS25J.
Is contract SPE2DR26FS25J an order under another contract?
Yes. SPE2DR26FS25J is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS25J competed?
The extent of competition for SPE2DR26FS25J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award